Viewing Study NCT02817750


Ignite Creation Date: 2025-12-24 @ 5:10 PM
Ignite Modification Date: 2026-01-25 @ 5:58 AM
Study NCT ID: NCT02817750
Status: COMPLETED
Last Update Posted: 2018-06-11
First Post: 2016-06-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation
Sponsor: Biolab Sanus Farmaceutica
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module